Potential bioreductive alkylating agents-VI. Determination of the relationship between oxidation-reduction potential and antineoplastic activity

Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021

A simple and inexpensive method to control oxygen concentrations within physiological and neoplastic ranges.

Analytical biochemistry·2015

Interaction of arsenic and phosphate on their uptake and accumulation in Chinese brake fern.

International journal of phytoremediation·2010

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.

Cancer chemotherapy and pharmacology·2004

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.

Cancer chemotherapy and pharmacology·2003

Synthesis of halogen-substituted 3-deazaadenosine and 3-deazaguanosine analogues as potential antitumor/antiviral agents.

Nucleosides, nucleotides & nucleic acids·2002

KAT2B epigenetically activates GSTZ1 via H3K9ac to suppress proliferation and stemness and enhance ferroptosis in oral squamous cell carcinoma.

Biochemical pharmacology·2026

Sigma-1 receptor involvement in the paradigm-dependent anti-amnesic effects of multimodal HBK-10 under NMDA receptor hypofunction, with accompanying hippocampal ERK1/2 and BDNF modulation.

Biochemical pharmacology·2026

Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K/AKT signaling and metabolic homeostasis.

Biochemical pharmacology·2026

β-Glucuronidase at the gut-liver interface: Structural selectivity, enterohepatic reactivation, and the pharmacomicrobiomic case for precision inhibition.

Biochemical pharmacology·2026

Identification of a small-molecule inhibitor of nardilysin and its pharmacological effects on transcriptional regulation and inflammatory arthritis.

Biochemical pharmacology·2026

MEX3A mediates DHRS3 instability to relieve G0/G1 arrest and facilitate hepatocellular carcinoma tumorigenesis and progression.

Biochemical pharmacology·2026

Does size matter? Tumor density as a predictor of clinically significant prostate cancer on MRI-targeted transperineal prostate biopsy.

International urology and nephrology·2026

Beyond the Document: A Single-Center Qualitative Study of Survivorship Care Plan Barriers and Opportunities Across Pediatric Oncology Stakeholders.

Pediatric blood & cancer·2026

A high-throughput method to computationally develop candidate adverse outcome pathways in humans: a proof of concept with insecticides and Parkinson Disease.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Endometriosis Pain: Genes linked to Inflammation Distinguish Symptomatic from Asymptomatic Disease.

Molecular human reproduction·2026

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Journal of the National Cancer Institute·2026

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

Journal of the National Cancer Institute·2026

Related Experiment Videos

Potential bioreductive alkylating agents-VI. Determination of the relationship between oxidation-reduction potential

Related Concept Videos

Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.

A simple and inexpensive method to control oxygen concentrations within physiological and neoplastic ranges.

Interaction of arsenic and phosphate on their uptake and accumulation in Chinese brake fern.

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.

Synthesis of halogen-substituted 3-deazaadenosine and 3-deazaguanosine analogues as potential antitumor/antiviral agents.

KAT2B epigenetically activates GSTZ1 via H3K9ac to suppress proliferation and stemness and enhance ferroptosis in oral squamous cell carcinoma.

Sigma-1 receptor involvement in the paradigm-dependent anti-amnesic effects of multimodal HBK-10 under NMDA receptor hypofunction, with accompanying hippocampal ERK1/2 and BDNF modulation.

Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K/AKT signaling and metabolic homeostasis.

β-Glucuronidase at the gut-liver interface: Structural selectivity, enterohepatic reactivation, and the pharmacomicrobiomic case for precision inhibition.

Identification of a small-molecule inhibitor of nardilysin and its pharmacological effects on transcriptional regulation and inflammatory arthritis.

MEX3A mediates DHRS3 instability to relieve G0/G1 arrest and facilitate hepatocellular carcinoma tumorigenesis and progression.

Does size matter? Tumor density as a predictor of clinically significant prostate cancer on MRI-targeted transperineal prostate biopsy.

Beyond the Document: A Single-Center Qualitative Study of Survivorship Care Plan Barriers and Opportunities Across Pediatric Oncology Stakeholders.

A high-throughput method to computationally develop candidate adverse outcome pathways in humans: a proof of concept with insecticides and Parkinson Disease.

Endometriosis Pain: Genes linked to Inflammation Distinguish Symptomatic from Asymptomatic Disease.

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

Related Experiment Videos

Potential bioreductive alkylating agents-VI. Determination of the relationship between oxidation-reduction potential...

Related Concept Videos

Related Articles

Potential bioreductive alkylating agents-VI. Determination of the relationship between oxidation-reduction potential